HepatoChem
Private Company
Total funding raised: $1.4M
Overview
HepatoChem is a private, revenue-generating tools and services company that has established itself as a leading innovator in photochemistry equipment since 2008. Its core business involves manufacturing and selling proprietary photoreactors, such as the PhotoRedOx Box and Lucent360, along with starter bundles and LEDs, to enable synthetic chemistry research in pharmaceutical and academic settings. With a global distributor network across the USA, Europe, and Asia, the company has successfully commercialized its platform, focusing on empowering drug discovery through advanced light-driven synthesis techniques. While not a therapeutic developer itself, HepatoChem's technology platform is foundational for modern small molecule and metabolite research.
Technology Platform
Suite of proprietary photoreactors, LED light sources, and integrated starter bundles for enabling photoredox catalysis and photochemical synthesis in laboratory settings.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Competes with other specialized photochemistry equipment providers and general lab instrument companies that may offer photoreactors. Maintains a competitive edge through its early-mover status, specialized product focus, integrated starter bundles, and strong global distributor network.